Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset
Recht M, He C, Chen E, Cheng D, Solari P, Hinds D. Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset. EJHaem 2022, 3: 341-352. PMID: 35846041, PMCID: PMC9176109, DOI: 10.1002/jha2.412.Peer-Reviewed Original ResearchHemophilia treatment centersSevere hemophilia AComprehensive care visitsHistory of inhibitorsTransfusion-transmitted infectionsClinical characteristicsHemophilia APlasma-derived factor productsReal-world dosingTreatment costsTreatment cost of patientsPrevalence of HBVPatient clinical characteristicsSubgroup of patientsPrevalence of HCVRetrospective cohort studySubpopulation of patientsHealthcare resource utilizationDrivers of resource utilizationAnnual cost of treatmentCare visitsHealth resource utilizationTreatment frequencyCosts of patientsAnnual treatment costs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply